School of Medicine
Showing 1-20 of 91 Results
-
Richard Haarburger
Postdoctoral Scholar, General Internal Medicine
BioRichard Haarburger is a postdoctoral scholar in general medicine with a background in economics. During his PhD, he worked on addressing measurement biases and data gaps, handling high-dimensional data, and quantifying the implications of heterogeneous technology adoption. During his time as a scientific trainee at the Joint Research Centre of the European Commission, he conducted policy research on Europe's competitiveness in industrial automation technologies and the increasing adoption of AI in manufacturing.
At Stanford, he applies causal inference methods to research questions in population health and epidemiology. His research interests include impact evaluation methods, causal machine learning, and the impact of AI on healthcare and the economy. -
Jen Haensel
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioI am a Research Scientist in the Roberts Vision Development & Oculomotor Lab at Stanford University’s Department of Ophthalmology, working at the intersection of vision science, neuroscience, and experimental psychology. My current research uses eye-tracking, photorefraction, and psychophysics to study oculomotor development and visual function in amblyopia, strabismus, and concussion. I also work on developing methodology to record accommodative measurements and gaze behaviour in dynamic, naturalistic settings.
I completed my PhD in Experimental Psychology at Birkbeck, University of London (UK), where I used advanced eye-tracking techniques to study the influence of postnatal experience on social gaze behaviour. Prior to joining Stanford, I also worked as a postdoctoral researcher at the University of Bath (UK), developing empirical human-robot interaction studies to inform the ethical design of humanoid robots. -
Meghan Halley
Assistant Professor (Research) of Pediatrics (Stanford Center for Biomedical Ethics)
BioMeghan Halley, PhD, MPH is Assistant Professor of Pediatrics (Research) in the Center for Biomedical Ethics at Stanford University School of Medicine. With training in medical anthropology, public health and health services research, her scholarship draws on multidisciplinary theoretical and methodological approaches to examine ethical, legal, social and policy questions arising in clinical and translational research. Her areas of expertise include the ethics of new genomic technologies, normative frameworks for integrating research and clinical care, challenges and opportunities in patient and community engagement, and the epistemic and ethical implications of valuing new health interventions. Her work has been funded by the National Institutes of Health, the Patient Centered Outcomes Research Institute, and the National Science Foundation and published in high-impact journals including the New England Journal of Medicine, Nature Genetics, and the American Journal of Bioethics.
-
Dina Hany
Postdoctoral Scholar, Biomedical Data Sciences
BioI am currently a postdoctoral researcher in the laboratory of Prof. Sylvia Plevritis, Department of Biomedical Data Sciences. My current work involves establishing drug testing platforms to evaluate tumor drug responses with respect to the tumor microenvironment and the its spatial organization. I hold a Ph.D. in Life Sciences (Pharmaceutical Sciences) from the University of Geneva, Switzerland, where I conducted research in Prof. Didier Picard's laboratory from 2017 to 2022. Prior to that, I earned a Master’s degree in Pharmacology and Experimental Therapeutics from Alexandria University, Egypt, and a Bachelor’s degree in Pharmacy with honors from Pharos University. My professional experience includes postdoctoral research in molecular pharmacology at UNIGE and a lecturer position in Pharmacotherapeutics and Cancer Biology at Pharos University. I have extensive teaching experience, supervising undergraduate and postgraduate courses, and have successfully guided master's thesis projects. My research has focused on endocrine resistance in breast cancer, utilizing CRISPR/Cas9 screens and exploring drug combinations, resulting in several relevant publications. I have presented my work at numerous conferences and received several awards, including the Ernst et Lucie Schmidheiny Fondation grant and the Ph.D. Booster prize from the faculty of medicine, Geneva, Switzerland. I am an active member of the Life Sciences Switzerland (LS2) and the European Association of Cancer Research (EACR).
-
Hoda Hashemi
Postdoctoral Scholar, Radiological Sciences Laboratory
BioHoda S. Hashemi is a postdoctoral scholar at the Ultrasound Imaging & Instrumentation Lab at Stanford University. She received her PhD in Electrical and Computer Engineering from the University of British Columbia (UBC) in 2023. She was also an ultrasound research intern in research and innovation team at DarkVision Technologies Inc. from 2021 to 2023. She holds a M.A.Sc. from Concordia University and a B.Sc. from Sharif University of Technology. Her research interests are ultrasound molecular imaging, elastography and AI in medical image processing. Her research has been funded by the NIH T32 Fellowship at Stanford, the Canadian NSERC Postdoctoral Fellowship, and the Ultrasound Imaging & Instrumentation Lab at Stanford University.
-
Muhammad Murtaza Hassan
Postdoctoral Scholar, Chemical and Systems Biology
BioMurtaza is a chemical biologist that joined the Gray Lab in July 2021 as a postdoctoral researcher. He developed his love for medicinal chemistry and chemical biology at the undergraduate level at the University of Toronto Mississauga which then motivated him to pursue an MSc (York University, Supervisor: Prof. Edward Lee-Ruff, 2017) and PhD (University of Toronto Mississauga, Supervisor: Patrick T. Gunning, 2021) in the field. His PhD work involved the development of some of the most potent and selective HDAC8 inhibitors known-to-date. It incorporated inhibitors with L-shaped conformational constraints to compliment the L-shaped HDAC8 pocket. His current work at the Gray Lab revolves around the development of first-in-class covalent inhibitors for recently discovered epigenetic targets that have been shown to synergize with anticancer immunotherapy. Additionally, he is interested in developing small-molecule chemoproteomic tools that can potentially expand our ability to target otherwise undruggable proteins, by using protein-protein interactions for cross-labelling/drugging interacting proteins.
